## Abstract Existing and emerging strategies for managing Lβdopaβinduced dyskinesias (LIDs) in patients with Parkinson disease have involved either delaying the introduction of Lβdopa therapy, treatment with an antidyskinetic agent, using a therapy or delivery system that can provide continuous dop
β¦ LIBER β¦
Therapies for dopaminergic-induced dyskinesias in parkinson disease
β Scribed by John R. Ponsford
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 44 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Therapies for dopaminergic-induced dyski
β
Mildred D. Gottwald; Michael J. Aminoff
π
Article
π
2011
π
John Wiley and Sons
π
English
β 230 KB
π 2 views
Accelerometric assessment of levodopa-in
β
J.I. Hoff; A.A. v/d Plas; E.A.H. Wagemans; J.J. van Hilten
π
Article
π
2001
π
John Wiley and Sons
π
English
β 102 KB
π 2 views
Our objective was to develop parameters for objective ambulatory measurements of levodopa-induced dyskinesias (LID) in patients with Parkinson's disease (PD). Twentythree PD patients with mild to severe LID were submitted to a standardized protocol of 1-minute recordings during rest, talking, stress
Continuous dopaminergic therapy in Parki
β
A. Jon Stoessl
π
Article
π
2010
π
John Wiley and Sons
π
English
β 59 KB
π 1 views
Pathogenesis of dyskinesias in parkinson
β
Dr. M. M. Mouradian; I. J. E. Heuser; F. Baronti; G. Fabbrini; J. L. Juncos; T.
π
Article
π
1989
π
John Wiley and Sons
π
English
β 363 KB
π 2 views
Beneficial effects of amantadine on L-do
β
E. Luginger; G. K. Wenning; S. BΓΆsch; W. Poewe
π
Article
π
2000
π
John Wiley and Sons
π
English
β 95 KB
π 2 views
Initiating therapy in Parkinson's diseas
β
William Weiner; Eric Ahlskog; Stewart Factor; Oksana Suchowersky; Stephen Reich
π
Article
π
2009
π
John Wiley and Sons
π
English
β 51 KB
π 1 views